Editor’s note: On 2 August 2022, JAMA (the Journal of the American Medical Association) published the article, “Effect of Graded Sensorimotor Retraining on Pain Intensity in Patients with Chronic Low Back Pain: A Randomized Clinical Trial.” This trial, which included 276 participants, sought to estimate the effect of a sensorimotor retraining intervention (RESOLVE) on pain intensity in people with chronic low back pain. In the podcast below, several of this study’s researchers speak with PRF contributor, Lincoln Tracy, PhD, Monash University, Melbourne, Australia. They discuss the trial’s design and setting, its main findings, and the future research resulting from this work.
Podcast participants include:
- Matthew Bagg, PhD, Centre for Pain IMPACT at NeuRA, Sydney, Australia, and the Curtin Health Innovation Research Institute at Curtin University, Perth, Australia
- Aidan Cashin, PhD, Centre for Pain IMPACT at NeuRA, Sydney, Australia, and the University of New South Wales
- Edel O’Hagan, PhD, Centre for Pain IMPACT at NeuRA, Sydney, Australia, and the Westmead Applied Research Centre at the University of Sydney, Australia
- James McAuley, PhD, Centre for Pain IMPACT at NeuRA, Sydney, Australia, and the University of New South Wales
- Lincoln Tracy, PhD, Monash University, Melbourne, Australia (host)
Podcast participants
Listen below and consider leaving a comment on the podcast at the bottom of this page. This PRF podcast is also available on Apple Podcasts here and Spotify here.
About the participants:
Matthew Bagg, PhD, is a clinical scientist and physiotherapist, working to improve understanding and healthcare for people with pain and nervous system conditions. Bagg is a research fellow within the Curtin Health Innovation Research Institute at Curtin University in Perth, Australia, and also a fellow at the Centre for Pain IMPACT at NeuRA, Sydney, Australia. Additionally, Bagg provides private clinical consultancy services in Perth. You can follow Bagg’s work here.
Aidan Cashin, PhD, is a postdoctoral fellow at the University of New South Wales, Australia, and the Centre for Pain IMPACT at NeuRA. His research focuses on how treatments for musculoskeletal pain work – looking at all aspects and mechanisms, both physical and psychological, that may confer benefits to patients who undertake them. Additionally, Cashin is the winner of IASP’s 2022 Ronald Dubner Research Prize (read PRF related interview here).
Edel O’Hagan, PhD, is an early-career research fellow at Westmead Applied Research Centre and a registered physiotherapist. She achieved her PhD at NeuRA, University of New South Wales. Her research focuses on understanding low back pain information from the perspective of consumers to facilitate patient-centered care.
James McAuley, PhD, is a professor in the Faculty of Medicine and Health at the University of New South Wales (UNSW), a Senior Research Scientist at NeuRA, and a National Health and Medical Research Council Leadership Fellow. He is a leader in the prevention and management of chronic pain. McAuley’s research program is accommodated within the NeuRA Centre for Pain IMPACT, which he founded and leads. The Centre, a collaboration between NeuRA, UNSW Sydney, Western University, Canada, and the University of Maryland, USA, supports ~40 researchers. McAuley has published over 220 research papers, including 16 randomized clinical trials and 30 systematic reviews. His research has been included in 14 clinical guidelines for the management of low back pain, including those produced by professional societies representing general medicine, physiotherapy and chiropractic. Additionally, McAuley has supervised 25 PhD, 1 Research Masters, and 5 Honors students, and he has mentored 5 postdoc fellows. He currently supervises 8 PhDs and 3 Honors students (view an IASP-PRF seminar with McAuley here).
Lincoln Tracy, PhD, is a freelance science writer, a research fellow at Monash University, Melbourne, Australia, and a frequent PRF contributor. You can fellow him on Twitter – @lincolntracy.
Featured image: Visual Abstract – Bagg et al, JAMA. 2022 August 2;328(5):430-439.